Your session is about to expire
← Back to Search
Behavioural Intervention
Approach Bias Training for Nicotine Addiction
N/A
Waitlist Available
Led By Lorra Garey, Ph.D
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1-7, 9, and 11 of participation
Summary
This trial will evaluate the effectiveness of a retraining program to help people quit smoking cigarettes and using electronic cigarettes. The study will follow 90 experienced users who are motivated to quit as they try to quit on their own.
Who is the study for?
This trial is for adults who've used both regular cigarettes and e-cigarettes with nicotine almost every day over the last month, can read and speak English fluently, want to quit nicotine (scoring at least 5 out of 10 in motivation), and own an Android smartphone. It's not for those currently getting treatment for mental illness or addiction, using other quitting aids like nicotine patches or certain medications, or unable to consent.
What is being tested?
The study tests a 'bias training' method to help people quit smoking by comparing three groups: one uses bias training for both cigarettes and e-cigs (CC+ECIG Condition), another only for cigarettes (CC Condition), while the third group gets a fake intervention (Sham Condition). Participants are randomly assigned to these groups during their self-guided attempt to stop using nicotine.
What are the potential side effects?
Since this trial involves behavioral interventions rather than medication, traditional side effects are not expected. However, participants may experience frustration or stress due to quitting attempts or possible cravings triggered during approach bias retraining exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1-7, 9, and 11 of participation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1-7, 9, and 11 of participation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Approach Bias
Biochemically-Verified Point Prevalence Abstinence
Lapse
+4 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: CC+ECIG ConditionExperimental Treatment1 Intervention
Combustible Cigarette (CC) and Electronic Cigarette (ECIG) users will be trained to avoid CC and ECIG-related images and approach positive images.
Group II: CC Only ConditionActive Control1 Intervention
Participants in this arm will be trained to avoid only combustible cigarette images, not electronic cigarettes images.
Group III: Sham ConditionPlacebo Group1 Intervention
Participants will pull and push all pictures of CC and ECIG images equally with no preference towards one or the other.
Find a Location
Who is running the clinical trial?
University of HoustonLead Sponsor
151 Previous Clinical Trials
47,843 Total Patients Enrolled
Lorra Garey, Ph.DPrincipal InvestigatorAssistant Research Professor